{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:06:21Z","timestamp":1793199981460,"version":"4.5.0"},"reference-count":206,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jhep.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:55:54Z","timestamp":1692330954000},"page":"1502-1523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["IgG4-related cholangitis \u2013 a mimicker of fibrosing and malignant cholangiopathies"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-5177","authenticated-orcid":false,"given":"Remco","family":"Kersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6621-4293","authenticated-orcid":false,"given":"David C.","family":"Trampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Herta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowiek M.","family":"Hubers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas J.","family":"Maillette de Buy Wenniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-4359","authenticated-orcid":false,"given":"Stan F.J.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-7799","authenticated-orcid":false,"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.08.005_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","article-title":"Clinical perspectives on IgG4-related disease and its classification","volume":"73","author":"Katz","year":"2022","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-021-00529-y","article-title":"IgG4-related diseases of the digestive tract","volume":"19","author":"L\u00f6hr","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A\u00a0new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.pas.0000136449.37936.6c","article-title":"IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?","volume":"28","author":"Zen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01879134","article-title":"Verschluss der Gallenwege durch Verdickung der Wandungen","volume":"39","author":"Hoffmann","year":"1867","journal-title":"Arch Pathol Anat Physiol"},{"key":"10.1016\/j.jhep.2023.08.005_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM196307042690102","article-title":"Sclerosing cholangitis: its possible association with Riedel\u2019s struma and fibrous retroperitonitis. Report of two cases","volume":"269","author":"Bartholomew","year":"1963","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02788570","article-title":"Primary sclerosing pancreatitis and cholangitis","volume":"24","author":"Kazumori","year":"1998","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)00603-0","article-title":"Sclerosing pancreato-cholangitis responsive to steroid therapy","volume":"354","author":"Erkelens","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jhep.2023.08.005_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41395-018-0036-5","article-title":"IgG4-Associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience","volume":"113","author":"Roos","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.08.005_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14397595.2019.1621000","article-title":"Genetic analysis of IgG4-related disease","volume":"30","author":"Ishikawa","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib13","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30006-2","article-title":"IgG4-related disease in the Japanese population: a genome-wide association study","volume":"1","author":"Terao","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146212","article-title":"IL1R1 gene variants associate with disease susceptibility to IgG4-related periaortitis\/periarteritis in IgG4-related disease","volume":"820","author":"Umemura","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.jhep.2023.08.005_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1572-0241.2007.01750.x","article-title":"Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients","volume":"103","author":"Umemura","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/gutjnl-2020-323565","article-title":"Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.08.005_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.2009.200972","article-title":"Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease","volume":"59","author":"Akitake","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.08.005_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/intimm\/dxz050","article-title":"Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells","volume":"31","author":"Kamata","year":"2019","journal-title":"Int Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib20","article-title":"Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas","volume":"3","author":"Hubers","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.08.005_bib21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.26999","article-title":"Exposure to occupational antigens might predispose to IgG4-related disease","volume":"60","author":"de Buy Wenniger","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib22","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1093\/rheumatology\/keab172","article-title":"The association of smoking with immunoglobulin G4-related disease: a case-control study","volume":"60","author":"Wallwork","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2023.08.005_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajim.4700190203","article-title":"Cancer by industry: analysis of a population-based cancer registry with an emphasis on blue-collar workers","volume":"19","author":"Hall","year":"1991","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib24","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-related disease with history of malignancy","volume":"68","author":"Wallace","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.jhep.2023.08.005_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jgh.16066","article-title":"Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: based on a Japanese nationwide study","volume":"38","author":"Kubota","year":"2023","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib26","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/hep.26232","article-title":"Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.08.005_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/art.41140","article-title":"Disease severity linked to increase in autoantibody diversity in IgG4-related disease","volume":"72","author":"Liu","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.jhep.2023.08.005_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG4-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib31","first-page":"728","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.08.005_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1152\/physrev.00030.2001","article-title":"Annexins: from structure to function","volume":"82","author":"Gerke","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2023.08.005_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2019.08.050","article-title":"RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether","volume":"179","author":"Liao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2023.08.005_bib34","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1172\/JCI116921","article-title":"Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis","volume":"92","author":"Beuers","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.08.005_bib35","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.08.005_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2021.10.009","article-title":"Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection","volume":"76","author":"Herta","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib41","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0168-8278(23)00525-1","article-title":"Laminin 511-E8 is an autoantigen in IgG4-related cholangitis patients that protects cholangiocytes against T lymphocyte-induced epithelial barrier dysfunction","volume":"78","author":"Trampert","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib42","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1038\/s41467-021-24184-8","article-title":"Structural mechanism of laminin recognition by integrin","volume":"12","author":"Arimori","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.08.005_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701497","article-title":"Mechanistic basis for the recognition of laminin-511 by \u03b16\u03b21 integrin","volume":"3","author":"Takizawa","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhep.2023.08.005_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2016.04.075","article-title":"Laminin 411 and 511 promote the cholangiocyte differentiation of human induced pluripotent stem cells","volume":"474","author":"Takayama","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2023.08.005_bib45","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.celrep.2016.12.092","article-title":"Endothelial basement membrane laminin 511 contributes to endothelial junctional tightness and thereby inhibits leukocyte transmigration","volume":"18","author":"Song","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2023.08.005_bib46","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1053\/j.gastro.2013.01.055","article-title":"Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier","volume":"144","author":"M\u00fcller","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.08.005_bib47","article-title":"High expression of galectin-3 in patients with IgG4-related disease: a proteomic approach","volume":"2017","author":"Salah","year":"2017","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.jhep.2023.08.005_bib48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cub.2005.12.046","article-title":"Requirement for galectin-3 in apical protein sorting","volume":"16","author":"Delacour","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.jhep.2023.08.005_bib49","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.213199","article-title":"Galectin-3 modulates the polarized surface delivery of \u03b21-integrin in epithelial cells","volume":"131","author":"H\u00f6nig","year":"2018","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jhep.2023.08.005_bib50","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fimmu.2019.01309","article-title":"Gal-3 deficiency suppresses novosphyngobium aromaticivorans inflammasome activation and IL-17 driven autoimmune cholangitis in mice","volume":"10","author":"Arsenijevic","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep23348","article-title":"Deletion of galectin-3 enhances xenobiotic induced murine primary biliary cholangitis by facilitating apoptosis of BECs and release of autoantigens","volume":"6","author":"Arsenijevic","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2023.08.005_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2023.08.005_bib53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/glycob\/cwp120","article-title":"Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells","volume":"19","author":"Oliveira","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jhep.2023.08.005_bib54","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/1535370215593826","article-title":"Galectin-3 in autoimmunity and autoimmune diseases","volume":"240","author":"de Oliveira","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jhep.2023.08.005_bib55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.bbamcr.2011.01.033","article-title":"The role and therapeutic potential of prohibitin in disease","volume":"1813","author":"Theiss","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2023.08.005_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125331","article-title":"Prohibitin is involved in patients with IgG4 related disease","volume":"10","author":"Du","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.08.005_bib57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.27959","article-title":"Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1","volume":"62","author":"Barbier-Torres","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib58","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1074\/jbc.M708232200","article-title":"The PHB1\/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells","volume":"283","author":"Ross","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2023.08.005_bib59","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4049\/jimmunol.1201646","article-title":"Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes","volume":"190","author":"Lucas","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14397595.2018.1536364","article-title":"Cytokines produced by innate immune cells in IgG4-related disease","volume":"29","author":"Yoshikawa","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib61","first-page":"115","article-title":"IgG4-Related disease and innate immunity","volume":"401","author":"Watanabe","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib62","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/MPA.0b013e31824a0e58","article-title":"Comparative study on experimental autoimmune pancreatitis and its extrapancreatic involvement in mice","volume":"41","author":"Yamashina","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.jhep.2023.08.005_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/srep42413","article-title":"Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease","volume":"7","author":"Furukawa","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2023.08.005_bib64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.41052","article-title":"Activated M2 macrophages contribute to the pathogenesis of IgG4-related disease via toll-like receptor 7\/interleukin-33 signaling","volume":"72","author":"Ishiguro","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.jhep.2023.08.005_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00535-012-0626-8","article-title":"Toll-like receptor activation in basophils contributes to the development of IgG4-related disease","volume":"48","author":"Watanabe","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib66","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.33386","article-title":"Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2023.08.005_bib67","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.42043","article-title":"CD163+ M2 macrophages promote fibrosis in IgG4-related disease via toll-like receptor 7\/interleukin-1 receptor-associated kinase 4\/NF-\u03baB signaling","volume":"74","author":"Chinju","year":"2022","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.jhep.2023.08.005_bib68","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.4049\/jimmunol.1700060","article-title":"Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-\u03b1 and IL-33 produced by plasmacytoid dendritic cells","volume":"198","author":"Watanabe","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib69","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.1500971","article-title":"Plasmacytoid dendritic cell activation and IFN-\u03b1 production are prominent features of murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis","volume":"195","author":"Arai","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/intimm\/dxu074","article-title":"IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity","volume":"26","author":"Umehara","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-related disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jhep.2023.08.005_bib73","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib74","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib75","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.jhep.2023.08.005_bib76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00535-010-0199-3","article-title":"Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases","volume":"45","author":"Koyabu","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib77","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T cells in the pathogenesis of IgG4-related disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2023.08.005_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/BOR.0000000000000558","article-title":"New insights into IgG4-related disease: emerging new CD4+ T-cell subsets","volume":"31","author":"Kamekura","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib80","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A\u00a0critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jhep.2023.08.005_bib81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2023.08.005_bib82","article-title":"Activated T-follicular helper 2 cells are associated with disease activity in IgG4-related sclerosing cholangitis and pancreatitis","volume":"10","author":"Cargill","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib83","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000111","article-title":"Expansion of a novel subset of PD1+CXCR5-CD4+ T peripheral helper cells in IgG4-related disease","volume":"11","author":"Cargill","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib84","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/mr\/roac141","article-title":"Perspectives on current and emerging therapies for immunoglobulin G4-related disease","volume":"33","author":"Tanaka","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651357","article-title":"Peripheral TIGIT+ T follicular helper cells that produce high levels of interleukin-21 via OX40 represent disease activity in IgG4-related disease","volume":"12","author":"Akiyama","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib86","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2020.05.022","article-title":"CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease","volume":"147","author":"Perugino","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.40469","article-title":"A\u00a0CD8\u03b1- subset of CD4+SLAMF7+ cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment","volume":"70","author":"Della-Torre","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.jhep.2023.08.005_bib88","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib89","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.176.6.3498","article-title":"Primary T cell expansion and differentiation in\u00a0vivo requires antigen presentation by B cells","volume":"176","author":"Crawford","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib90","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib91","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2017.07.024","article-title":"Expansion of blood IgG4+ B, TH2, and regulatory T cells in patients with IgG4-related disease","volume":"141","author":"Heeringa","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib92","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaci.2019.07.004","article-title":"B\u00a0lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease","volume":"145","author":"Della-Torre","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib93","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","article-title":"B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease","volume":"74","author":"Della-Torre","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib94","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13075-018-1718-5","article-title":"Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse","volume":"20","author":"Lanzillotta","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2023.08.005_bib95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/BOR.0000000000000686","article-title":"Immune mechanisms of fibrosis and inflammation in IgG4-related disease","volume":"32","author":"Pillai","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib96","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cgh.2016.12.038","article-title":"Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis","volume":"15","author":"Tanaka","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib97","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort","volume":"109","author":"Huggett","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American college of rheumatology\/European league against rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib99","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/bjs.6057","article-title":"Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures","volume":"95","author":"Erdogan","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2023.08.005_bib100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00534-011-0436-z","article-title":"Inflammatory pseudotumors mimicking intrahepatic cholangiocarcinoma of the liver; IgG4-positivity and its clinical significance","volume":"19","author":"Ahn","year":"2012","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2023.08.005_bib101","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/modpathol.3800836","article-title":"Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease","volume":"20","author":"Zen","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib102","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2169\/internalmedicine.46.6430","article-title":"Inflammatory pseudotumors of the pancreas and liver with infiltration of IgG4-positive plasma cells","volume":"46","author":"Uchida","year":"2007","journal-title":"Intern Med"},{"issue":"Suppl 18","key":"10.1016\/j.jhep.2023.08.005_bib103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","article-title":"Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic\u2019s HISORt criteria","volume":"42","author":"Chari","year":"2007","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib104","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0036-1584319","article-title":"The pathology of IgG4-related disease in the bile duct and pancreas","volume":"36","author":"Zen","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib106","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib107","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00535-010-0319-0","article-title":"Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation","volume":"46","author":"Naitoh","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib108","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1440-1746.2010.06346.x","article-title":"IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater\u2019s ampulla and the bile duct","volume":"25","author":"Kawakami","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib109","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.gie.2009.12.004","article-title":"IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis","volume":"71","author":"Moon","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2023.08.005_bib110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1148\/rg.315105735","article-title":"IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations","volume":"31","author":"Vlachou","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.jhep.2023.08.005_bib111","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2214\/AJR.12.10360","article-title":"Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis","volume":"202","author":"Tokala","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2023.08.005_bib112","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.mayocpiqo.2021.03.005","article-title":"Diagnosing biliary strictures: distinguishing IgG4-related sclerosing cholangitis from cholangiocarcinoma and primary sclerosing cholangitis","volume":"5","author":"Hori","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.jhep.2023.08.005_bib113","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.mpa.0000202941.85955.07","article-title":"Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography","volume":"32","author":"Nakazawa","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.jhep.2023.08.005_bib114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","article-title":"Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification","volume":"47","author":"Nakazawa","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib115","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00261-019-01944-1","article-title":"Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center","volume":"44","author":"Swensson","year":"2019","journal-title":"Abdom Radiol (New York)"},{"key":"10.1016\/j.jhep.2023.08.005_bib116","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00535-009-0108-9","article-title":"Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis","volume":"44","author":"Naitoh","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib117","first-page":"638","article-title":"18F-fluorodeoxyglucose PET and PET\/computed tomography for the evaluation\u00a0of immunoglobulin G4-related disease: a systematic review","volume":"43","author":"Dondi","year":"2022","journal-title":"Nucl Med\u00a0Commun"},{"key":"10.1016\/j.jhep.2023.08.005_bib118","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12149-022-01749-1","article-title":"Clinical value of 18F-FDG PET\/CT in IgG4-related disease","volume":"36","author":"Bai","year":"2022","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib119","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","article-title":"Characterizing IgG4-related disease with 18F-FDG PET\/CT: a prospective cohort study","volume":"41","author":"Zhang","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jhep.2023.08.005_bib120","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1007\/s00261-015-0543-4","article-title":"Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy","volume":"40","author":"Gardner","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jhep.2023.08.005_bib121","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib122","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/2050640620934911","article-title":"European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhep.2023.08.005_bib123","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/BOR.0b013e3283413469","article-title":"Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis","volume":"23","author":"Sah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib124","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib125","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.08.005_bib126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/2050640620916027","article-title":"Immunoglobulin G subtypes-1 and 2 differentiate immunoglobulin G4-associated sclerosing cholangitis from primary sclerosing cholangitis","volume":"8","author":"Vujasinovic","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhep.2023.08.005_bib127","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365521.2017.1416159","article-title":"The significance of serum IgG4 and CA19-9, autoantibodies in diagnosis and differential diagnosis of IgG4-related sclerosing cholangitis","volume":"53","author":"Tan","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib129","article-title":"IgG4\/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer","volume":"2","author":"de Vries","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.08.005_bib130","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.15192","article-title":"A\u00a0novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis","volume":"42","author":"Radford-Smith","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.08.005_bib131","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","article-title":"Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience","volume":"4","author":"Chari","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103273","article-title":"Development of an algorithm for IgG4-related disease management","volume":"22","author":"Orozco-G\u00e1lvez","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2023.08.005_bib133","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/1756-185X.13088","article-title":"Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial","volume":"20","author":"Wu","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib136","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib137","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40674-020-00147-w","article-title":"Therapeutic options in IgG4-related disease","volume":"6","author":"Fern\u00e1ndez-Codina","year":"2020","journal-title":"Curr Treat Options Rheumatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib138","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.semarthrit.2020.01.010","article-title":"Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: a randomized clinical trial","volume":"50","author":"Wang","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jhep.2023.08.005_bib139","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/key227","article-title":"Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial","volume":"58","author":"Yunyun","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2023.08.005_bib140","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","article-title":"Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids","volume":"7","author":"Yunyun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2023.08.005_bib141","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fmed.2020.00253","article-title":"Comparison of the effects of cyclophosphamide and mycophenolate mofetil treatment against immunoglobulin G4-related disease: a retrospective cohort study","volume":"7","author":"Luo","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib142","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.cgh.2018.02.049","article-title":"Rituximab maintenance therapy reduces rate of relapse of pancreaticobiliary immunoglobulin G4-related disease","volume":"16","author":"Majumder","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib143","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib144","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2023.08.005_bib145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance glucocorticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.08.005_bib146","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib147","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib148","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00535-020-01714-7","article-title":"The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience","volume":"55","author":"Ali","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib149","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jhbp.957","article-title":"IgG4-related sclerosing cholangitis may be a risk factor for cancer","volume":"28","author":"Kurita","year":"2021","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2023.08.005_bib151","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/rheumatology\/kew479","article-title":"BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs","volume":"56","author":"Ledingham","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2023.08.005_bib152","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jhep.2023.08.005_bib153","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","article-title":"EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases","volume":"72","author":"Duru","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-9-1","article-title":"Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature","volume":"9","author":"Mannion","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jhep.2023.08.005_bib155","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.14309\/crj.2016.88","article-title":"Autoimmune pancreatitis and IgG4 related disease in three children","volume":"3","author":"Bolia","year":"2016","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jhep.2023.08.005_bib156","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0034-1398475","article-title":"IgG4-sclerosing cholangitis in a pediatric patient","volume":"35","author":"Rosen","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-016-0079-3","article-title":"IgG4-related disease: a systematic review of this unrecognized disease in pediatrics","volume":"14","author":"Karim","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jhep.2023.08.005_bib158","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2023.08.005_bib159","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MPG.0000000000002028","article-title":"Recommendations for diagnosis and management of autoimmune pancreatitis in childhood: consensus from INSPPIRE","volume":"67","author":"Scheers","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2023.08.005_bib160","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2023.08.005_bib161","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.dld.2021.02.009","article-title":"Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort","volume":"53","author":"Naitoh","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2023.08.005_bib162","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009767","article-title":"Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis: A retrospective cohort study of 39 IAC patients","volume":"97","author":"Xiao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2023.08.005_bib163","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2017.05.018","article-title":"Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC\/AIH and PSC alone","volume":"16","author":"Lian","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2023.08.005_bib164","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.urology.2013.04.046","article-title":"Testicular inflammation as a new manifestation of IgG4-associated disease","volume":"82","author":"de Buy Wenniger","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.jhep.2023.08.005_bib165","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/gast.1996.v110.pm8613065","article-title":"Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sj\u00f6gren\u2019s syndrome","volume":"110","author":"Kino-Ohsaki","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.08.005_bib166","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jcmm.13000","article-title":"Sera of patients with spontaneous tumour regression and elevated anti-CA I autoantibodies change the gene expression of ECM proteins","volume":"21","author":"Lakota","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib167","first-page":"26","article-title":"Carbonic anhydrase I and II autoantibodies in Beh\u00e7et\u2019s disease","volume":"42","author":"Mentese","year":"2017","journal-title":"Acta Reum Port"},{"key":"10.1016\/j.jhep.2023.08.005_bib168","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4274\/tjo.99233","article-title":"The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients","volume":"47","author":"T\u00fcrk","year":"2017","journal-title":"Turkish J Ophthalmol"},{"key":"10.1016\/j.jhep.2023.08.005_bib169","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/gut.2004.049064","article-title":"Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis","volume":"54","author":"Nishimori","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.08.005_bib170","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/354594","article-title":"Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure","volume":"2012","author":"Liu","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib171","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(00)70264-2","article-title":"Autoimmune-related pancreatitis is associated with autoantibodies and a Th1\/Th2-type cellular immune response","volume":"118","author":"Okazaki","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.08.005_bib172","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.mpa.0000226881.48204.fd","article-title":"Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis","volume":"33","author":"Asada","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.jhep.2023.08.005_bib173","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4757-9068-9_39","article-title":"Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis","volume":"443","author":"Roozendaal","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jhep.2023.08.005_bib174","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2337\/db08-0493","article-title":"Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes","volume":"58","author":"Endo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2023.08.005_bib175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2009.06.009","article-title":"HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes","volume":"386","author":"Takizawa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2023.08.005_bib176","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/ajg.2010.141","article-title":"Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process","volume":"105","author":"L\u00f6hr","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib177","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa0903068","article-title":"Identification of a novel antibody associated with autoimmune pancreatitis","volume":"361","author":"Frulloni","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib178","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10753-015-0284-0","article-title":"Antibodies to Type IV Collagen Induce Type 1 Autoimmune Pancreatitis","volume":"39","author":"Liu","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.jhep.2023.08.005_bib179","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaci.2021.05.002","article-title":"Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease","volume":"149","author":"Jarrell","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib180","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbrc.2014.07.126","article-title":"Identification of prohibitin as an antigen in Behcet\u2019s disease","volume":"451","author":"Xun","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2023.08.005_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109197","article-title":"Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1\u03b2 in systemic lupus erythematosus","volume":"112","author":"Shi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jhep.2023.08.005_bib182","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1023\/A:1012240719801","article-title":"Anti-Galectin-3 IgG autoantibodies in patients with Crohn\u2019s disease characterized by means of phage display peptide libraries","volume":"21","author":"Jensen-Jarolim","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhep.2023.08.005_bib183","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/096120330000900707","article-title":"Determination of autoantibodies to annexin XI in systemic autoimmune diseases","volume":"9","author":"Jorgensen","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jhep.2023.08.005_bib184","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mpdhp.2013.01.007","article-title":"Hepatobiliary manifestations of IgG4-related disease","volume":"19","author":"Zen","year":"2013","journal-title":"Diagnostic Histopathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2559.2011.04078.x","article-title":"Follicular cholangitis and pancreatitis - clinicopathological features and differential diagnosis of an under-recognized entity","volume":"60","author":"Zen","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jhep.2023.08.005_bib186","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/PAS.0b013e31825faae0","article-title":"Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy","volume":"36","author":"Zen","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib187","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5107(04)02229-1","article-title":"Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis","volume":"60","author":"Nakazawa","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2023.08.005_bib188","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/0284185113481018","article-title":"Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI","volume":"54","author":"Kim","year":"2013","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jhep.2023.08.005_bib189","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/978-1-4757-9182-2_99","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease","volume":"336","author":"Mulder","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jhep.2023.08.005_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112877","article-title":"PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)","volume":"9","author":"Stinton","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.08.005_bib191","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","article-title":"Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA","volume":"10","author":"Qin","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib192","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4103\/JLP.JLP_63_19","article-title":"Inflammatory pseudotumors of the liver: Importance of a multimodal approach with the insistance of needle biopsy","volume":"11","author":"Nigam","year":"2019","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.jhep.2023.08.005_bib193","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2169\/internalmedicine.4611-20","article-title":"A Resected Case of Follicular Cholangitis That Was Positive on 18F-fluorodeoxyglucose-positron Emission Tomography","volume":"59","author":"Kosone","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.jhep.2023.08.005_bib194","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/jgh.14966","article-title":"Hepatobiliary and pancreatic: Follicular cholangitis mimicking perihilar cholangiocarcinoma","volume":"35","author":"Iwano","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.08.005_bib195","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/hepr.13380","article-title":"Follicular cholangitis mimicking cholangiocarcinoma treated with right hepatectomy: A case report and review of published works","volume":"49","author":"Chang","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2023.08.005_bib196","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12328-013-0441-7","article-title":"A case of follicular cholangitis mimicking hilar cholangiocarcinoma","volume":"7","author":"Fujii","year":"2014","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib197","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1872-034X.2010.00716.x","article-title":"Clinical and histopathological study of \"follicular cholangitis\": Sclerosing cholangitis with prominent lymphocytic infiltration masquerading as hilar cholangiocarcinoma","volume":"40","author":"Fujita","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2023.08.005_bib198","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3892\/mco.2015.659","article-title":"Follicular cholangitis associated with focal biliary stricture treated with left hepatectomy after 8 years of follow-up: A rare case report","volume":"4","author":"Saito","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jhep.2023.08.005_bib199","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/pin.12427","article-title":"Reversible sclerosing cholangitis with ulcerative colitis","volume":"66","author":"Kakisaka","year":"2016","journal-title":"Pathol Int"},{"key":"10.1016\/j.jhep.2023.08.005_bib200","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1097\/MPG.0b013e3182487173","article-title":"Steroid-responsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions","volume":"56","author":"Grammatikopoulos","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2023.08.005_bib201","first-page":"20","article-title":"Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis","volume":"30","author":"Nakazawa","year":"2005","journal-title":"Pancreas"},{"key":"10.1016\/j.jhep.2023.08.005_bib202","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00535-007-2038-8","article-title":"Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis","volume":"42","author":"Nishino","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.08.005_bib203","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/PAS.0000000000001767","article-title":"Fibrohistiocytic variant of hepatic pseudotumor: an antibiotic responsive tumefactive lesion","volume":"45","author":"Arora","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2023.08.005_bib204","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.jhep.2023.08.005_bib205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.08.005_bib206","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.pan.2021.06.009","article-title":"Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis","volume":"21","author":"Lanzillotta","year":"2021","journal-title":"Pancreatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823050584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823050584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:51:30Z","timestamp":1759175490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823050584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":206,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0168827823050584"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.08.005","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-related cholangitis \u2013 a mimicker of fibrosing and malignant cholangiopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}